This interrupted time series analysis evaluates the association of nudges with zoledronate prescription vs more expensive denosumab.
No takes yet. Share an insight, caveat, or question.
Takvorian et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: